SSTR5 and pituitary gland adenoma: Interestingly, when results from both GHomas and ACTHomas are viewed together, we observed two common, distinctive molecular signatures, namely, a lower sst5 expression in stimulated vs. inhibited pituitary adenomas, and a higher D2 expression level as compared with sst5 expression in stimulated pituitary adenomas.